{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T08:42:55Z","timestamp":1790757775194,"version":"4.1.0"},"reference-count":66,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1124\/dmd.120.090886","type":"journal-article","created":{"date-parts":[[2020,8,6]],"date-time":"2020-08-06T02:48:04Z","timestamp":1596682084000},"page":"944-955","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Human Amyloid-\u03b240 Kinetics after Intravenous and Intracerebroventricular Injections and Calcitriol Treatment in Rats In Vivo"],"prefix":"10.1016","volume":"48","author":[{"given":"H. Benson","family":"Peng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keumhan","family":"Noh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie R.","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Saldivia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvia","family":"Serson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja","family":"Toscan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In\u00e9s A.M.","family":"de Lannoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. Sandy","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/dmd.120.090886_bib1","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1124\/jpet.108.140327","article-title":"Dynamics of Abeta turnover and deposition in different beta-amyloid precursor protein transgenic mouse models following gamma-secretase inhibition","volume":"327","author":"Abramowski","year":"2008","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.120.090886_bib2","doi-asserted-by":"crossref","first-page":"20164","DOI":"10.1038\/srep20164","article-title":"Transthyretin participates in beta-amyloid transport from the brain to the liver--involvement of the low-density lipoprotein receptor-related protein 1?","volume":"6","author":"Alemi","year":"2016","journal-title":"Sci Rep"},{"key":"10.1124\/dmd.120.090886_bib3","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1038\/nm1438","article-title":"Human amyloid-beta synthesis and clearance rates as measured in cerebrospinal fluid in vivo","volume":"12","author":"Bateman","year":"2006","journal-title":"Nat Med"},{"key":"10.1124\/dmd.120.090886_bib4","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/mp.2008.96","article-title":"Clearance mechanisms of Alzheimer\u2019s amyloid-beta peptide: implications for therapeutic design and diagnostic tests","volume":"14","author":"Bates","year":"2009","journal-title":"Mol Psychiatry"},{"key":"10.1124\/dmd.120.090886_bib5","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1038\/sj.jcbfm.9600419","article-title":"Transport pathways for clearance of human Alzheimer\u2019s amyloid beta-peptide and apolipoproteins E and J in the mouse central nervous system","volume":"27","author":"Bell","year":"2007","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1124\/dmd.120.090886_bib6","doi-asserted-by":"crossref","first-page":"32916","DOI":"10.1074\/jbc.271.51.32916","article-title":"Amyloid beta-peptide is transported on lipoproteins and albumin in human plasma","volume":"271","author":"Biere","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1124\/dmd.120.090886_bib7","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/BF01061504","article-title":"Statistical estimations in pharmacokinetics","volume":"2","author":"Boxenbaum","year":"1974","journal-title":"J Pharmacokinet Biopharm"},{"key":"10.1124\/dmd.120.090886_bib8","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1124\/jpet.111.179101","article-title":"1alpha,25-dihydroxyvitamin D3 up-regulates P-glycoprotein via the vitamin D receptor and not farnesoid X receptor in both fxr(-\/-) and fxr(+\/+) mice and increased renal and brain efflux of digoxin in mice in vivo","volume":"337","author":"Chow","year":"2011","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.120.090886_bib9","doi-asserted-by":"crossref","first-page":"8844","DOI":"10.1523\/JNEUROSCI.23-26-08844.2003","article-title":"In vivo assessment of brain interstitial fluid with microdialysis reveals plaque-associated changes in amyloid-beta metabolism and half-life","volume":"23","author":"Cirrito","year":"2003","journal-title":"J Neurosci"},{"key":"10.1124\/dmd.120.090886_bib10","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1023\/A:1018943613122","article-title":"Physiological parameters in laboratory animals and humans","volume":"10","author":"Davies","year":"1993","journal-title":"Pharm Res"},{"key":"10.1124\/dmd.120.090886_bib11","doi-asserted-by":"crossref","first-page":"16","DOI":"10.2174\/187152709787601867","article-title":"Clearance of amyloid-beta peptide across the blood-brain barrier: implication for therapies in Alzheimer\u2019s disease","volume":"8","author":"Deane","year":"2009","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"10.1124\/dmd.120.090886_bib12","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1080\/17460441.2017.1380623","article-title":"Novel CNS drug discovery and development approach: model-based integration to predict neuro-pharmacokinetics and pharmacodynamics","volume":"12","author":"de Lange","year":"2017","journal-title":"Expert Opin Drug Discov"},{"key":"10.1124\/dmd.120.090886_bib13","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1111\/jnc.12041","article-title":"1\u03b1,25-Dihydroxyvitamin D3-liganded vitamin D receptor increases expression and transport activity of P-glycoprotein in isolated rat brain capillaries and human and rat brain microvessel endothelial cells","volume":"123","author":"Durk","year":"2012","journal-title":"J Neurochem"},{"key":"10.1124\/dmd.120.090886_bib14","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1007\/s11095-014-1524-y","article-title":"Vitamin D receptor activation induces P-glycoprotein and increases brain efflux of quinidine: an intracerebral microdialysis study in conscious rats","volume":"32","author":"Durk","year":"2015","journal-title":"Pharm Res"},{"key":"10.1124\/dmd.120.090886_bib15","doi-asserted-by":"crossref","first-page":"7091","DOI":"10.1523\/JNEUROSCI.2711-13.2014","article-title":"1\u03b1,25-Dihydroxyvitamin D3 reduces cerebral amyloid-\u03b2 accumulation and improves cognition in mouse models of Alzheimer\u2019s disease","volume":"34","author":"Durk","year":"2014","journal-title":"J Neurosci"},{"key":"10.1124\/dmd.120.090886_bib16","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1002\/cne.21808","article-title":"Differential expression of the multidrug resistance-related proteins ABCb1 and ABCc1 between blood-brain interfaces","volume":"510","author":"Gazzin","year":"2008","journal-title":"J Comp Neurol"},{"key":"10.1124\/dmd.120.090886_bib17","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/0306-4522(96)00281-3","article-title":"Rapid distribution of intraventricularly administered sucrose into cerebrospinal fluid cisterns via subarachnoid velae in rat","volume":"75","author":"Ghersi-Egea","year":"1996","journal-title":"Neuroscience"},{"key":"10.1124\/dmd.120.090886_bib18","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1046\/j.1471-4159.1996.67020880.x","article-title":"Fate of cerebrospinal fluid-borne amyloid beta-peptide: rapid clearance into blood and appreciable accumulation by cerebral arteries","volume":"67","author":"Ghersi-Egea","year":"1996","journal-title":"J Neurochem"},{"key":"10.1124\/dmd.120.090886_bib19","doi-asserted-by":"crossref","first-page":"45897","DOI":"10.1074\/jbc.M407668200","article-title":"Systemic catabolism of Alzheimer\u2019s Abeta40 and Abeta42","volume":"279","author":"Ghiso","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1124\/dmd.120.090886_bib20","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/357500a0","article-title":"Targeting of cell-surface beta-amyloid precursor protein to lysosomes: alternative processing into amyloid-bearing fragments","volume":"357","author":"Haass","year":"1992","journal-title":"Nature"},{"key":"10.1124\/dmd.120.090886_bib22","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1126\/science.1566067","article-title":"Alzheimer\u2019s disease: the amyloid cascade hypothesis","volume":"256","author":"Hardy","year":"1992","journal-title":"Science"},{"key":"10.1124\/dmd.120.090886_bib23","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1038\/nm0997-1016","article-title":"Distinct sites of intracellular production for Alzheimer\u2019s disease A beta40\/42 amyloid peptides","volume":"3","author":"Hartmann","year":"1997","journal-title":"Nat Med"},{"key":"10.1124\/dmd.120.090886_bib25","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.pharmthera.2005.03.010","article-title":"Metabolism of amyloid-beta peptide and Alzheimer\u2019s disease","volume":"108","author":"Iwata","year":"2005","journal-title":"Pharmacol Ther"},{"key":"10.1124\/dmd.120.090886_bib26","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/72237","article-title":"Identification of the major Abeta1-42-degrading catabolic pathway in brain parenchyma: suppression leads to biochemical and pathological deposition","volume":"6","author":"Iwata","year":"2000","journal-title":"Nat Med"},{"key":"10.1124\/dmd.120.090886_bib27","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1038\/nprot.2010.72","article-title":"Preparation and characterization of toxic Abeta aggregates for structural and functional studies in Alzheimer\u2019s disease research","volume":"5","author":"Jan","year":"2010","journal-title":"Nat Protoc"},{"key":"10.1124\/dmd.120.090886_bib29","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1124\/jpet.104.081901","article-title":"Pharmacokinetic analysis of the blood-brain barrier transport of 125I-amyloid beta protein 40 in wild-type and Alzheimer\u2019s disease transgenic mice (APP,PS1) and its implications for amyloid plaque formation","volume":"313","author":"Kandimalla","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.120.090886_bib30","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1124\/jpet.105.095711","article-title":"Physiological and biophysical factors that influence Alzheimer\u2019s disease amyloid plaque targeting of native and putrescine modified human amyloid beta40","volume":"318","author":"Kandimalla","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.120.090886_bib31","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1124\/jpet.107.119883","article-title":"Pharmacokinetics and amyloid plaque targeting ability of a novel peptide-based magnetic resonance contrast agent in wild-type and Alzheimer\u2019s disease transgenic mice","volume":"322","author":"Kandimalla","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.120.090886_bib33","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1006\/bbrc.1999.0552","article-title":"High levels of circulating Abeta42 are sequestered by plasma proteins in Alzheimer\u2019s disease","volume":"257","author":"Kuo","year":"1999","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1124\/dmd.120.090886_bib34","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1046\/j.1471-4159.2001.00113.x","article-title":"beta-Amyloid efflux mediated by p-glycoprotein","volume":"76","author":"Lam","year":"2001","journal-title":"J Neurochem"},{"key":"10.1124\/dmd.120.090886_bib35","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jneumeth.2006.03.023","article-title":"Demonstration of a common artifact in immunosorbent assays of brain extracts: development of a solid-phase extraction protocol to enable measurement of amyloid-beta from wild-type rodent brain","volume":"157","author":"Lanz","year":"2006","journal-title":"J Neurosci Methods"},{"key":"10.1124\/dmd.120.090886_bib36","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with the Folin phenol reagent","volume":"193","author":"Lowry","year":"1951","journal-title":"J Biol Chem"},{"key":"10.1124\/dmd.120.090886_bib37","doi-asserted-by":"crossref","first-page":"e0203659","DOI":"10.1371\/journal.pone.0203659","article-title":"Impaired hepatic amyloid-beta degradation in Alzheimer\u2019s disease","volume":"13","author":"Maarouf","year":"2018","journal-title":"PLoS One"},{"key":"10.1124\/dmd.120.090886_bib38","doi-asserted-by":"crossref","first-page":"325","DOI":"10.3233\/JAD-2009-0964","article-title":"Peripheral amyloid-beta levels regulate amyloid-beta clearance from the central nervous system","volume":"16","author":"Marques","year":"2009","journal-title":"J Alzheimers Dis"},{"key":"10.1124\/dmd.120.090886_bib39","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1126\/science.1197623","article-title":"Decreased clearance of CNS beta-amyloid in Alzheimer\u2019s disease","volume":"330","author":"Mawuenyega","year":"2010","journal-title":"Science"},{"key":"10.1124\/dmd.120.090886_bib40","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1208\/s12248-017-0110-8","article-title":"SLC and ABC transporters: expression, localization, and species differences at the blood-brain and the blood-cerebrospinal fluid barriers","volume":"19","author":"Morris","year":"2017","journal-title":"AAPS J"},{"key":"10.1124\/dmd.120.090886_bib41","doi-asserted-by":"crossref","first-page":"33400","DOI":"10.1074\/jbc.M109.054056","article-title":"Depletion of vitamin E increases amyloid beta accumulation by decreasing its clearances from brain and blood in a mouse model of Alzheimer disease","volume":"284","author":"Nishida","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1124\/dmd.120.090886_bib42","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1517\/17425247.2016.1171315","article-title":"CSF, blood-brain barrier, and brain drug delivery","volume":"13","author":"Pardridge","year":"2016","journal-title":"Expert Opin Drug Deliv"},{"key":"10.1124\/dmd.120.090886_bib43","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/2045-8118-8-21","article-title":"Amyloid-beta transporter expression at the blood-CSF barrier is age-dependent","volume":"8","author":"Pascale","year":"2011","journal-title":"Fluids Barriers CNS"},{"key":"10.1124\/dmd.120.090886_bib44","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1006\/nbdi.1999.0238","article-title":"Receptor-mediated transport of human amyloid beta-protein 1-40 and 1-42 at the blood-brain barrier","volume":"6","author":"Poduslo","year":"1999","journal-title":"Neurobiol Dis"},{"key":"10.1124\/dmd.120.090886_bib45","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.neuropharm.2014.01.023","article-title":"Differences in amyloid-\u03b2 clearance across mouse and human blood-brain barrier models: kinetic analysis and mechanistic modeling","volume":"79","author":"Qosa","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1124\/dmd.120.090886_bib46","doi-asserted-by":"crossref","first-page":"3900","DOI":"10.1073\/pnas.96.7.3900","article-title":"Choroid plexus epithelial expression of MDR1 P glycoprotein and multidrug resistance-associated protein contribute to the blood-cerebrospinal-fluid drug-permeability barrier","volume":"96","author":"Rao","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/dmd.120.090886_bib47","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.neuroscience.2008.06.015","article-title":"Subcellular localization of transporters along the rat blood-brain barrier and blood-cerebral-spinal fluid barrier by in vivo biotinylation","volume":"155","author":"Roberts","year":"2008","journal-title":"Neuroscience"},{"key":"10.1124\/dmd.120.090886_bib48","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1021\/acschemneuro.5b00180","article-title":"Role of species-specific primary structure differences in A\u03b242 assembly and neurotoxicity","volume":"6","author":"Roychaudhuri","year":"2015","journal-title":"ACS Chem Neurosci"},{"key":"10.1124\/dmd.120.090886_bib50","doi-asserted-by":"crossref","first-page":"a006379","DOI":"10.1101\/cshperspect.a006379","article-title":"Proteolytic degradation of amyloid \u03b2-protein","volume":"2","author":"Saido","year":"2012","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1124\/dmd.120.090886_bib51","doi-asserted-by":"crossref","first-page":"10227","DOI":"10.1073\/pnas.92.22.10227","article-title":"Vector-mediated delivery of 125I-labeled beta-amyloid peptide A beta 1-40 through the blood-brain barrier and binding to Alzheimer disease amyloid of the A beta 1-40\/vector complex","volume":"92","author":"Saito","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/dmd.120.090886_bib52","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.anorl.2011.03.002","article-title":"Anatomy and physiology of cerebrospinal fluid","volume":"128","author":"Sakka","year":"2011","journal-title":"Eur Ann Otorhinolaryngol Head Neck Dis"},{"key":"10.1124\/dmd.120.090886_bib53","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1136\/jnnp.2010.205757","article-title":"Plasma Abeta42 and Abeta40 as markers of cognitive change in follow-up: a prospective, longitudinal, population-based cohort study","volume":"81","author":"Sepp\u00e4l\u00e4","year":"2010","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1124\/dmd.120.090886_bib54","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1172\/JCI10498","article-title":"Clearance of Alzheimer\u2019s amyloid-ss(1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier","volume":"106","author":"Shibata","year":"2000","journal-title":"J Clin Invest"},{"key":"10.1124\/dmd.120.090886_bib55","doi-asserted-by":"crossref","first-page":"9632","DOI":"10.1523\/JNEUROSCI.2236-04.2004","article-title":"Brain insulin impairs amyloid-beta(1-40) clearance from the brain","volume":"24","author":"Shiiki","year":"2004","journal-title":"J Neurosci"},{"key":"10.1124\/dmd.120.090886_bib56","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.2741\/4035","article-title":"Reviewing reasons for the decreased CSF Abeta42 concentration in Alzheimer disease","volume":"17","author":"Spies","year":"2012","journal-title":"Front Biosci"},{"key":"10.1124\/dmd.120.090886_bib57","doi-asserted-by":"crossref","first-page":"11612","DOI":"10.1074\/jbc.M210207200","article-title":"In vitro characterization of conditions for amyloid-beta peptide oligomerization and fibrillogenesis","volume":"278","author":"Stine","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1124\/dmd.120.090886_bib58","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1007\/s11095-006-0208-7","article-title":"Major involvement of low-density lipoprotein receptor-related protein 1 in the clearance of plasma free amyloid beta-peptide by the liver","volume":"23","author":"Tamaki","year":"2006","journal-title":"Pharm Res"},{"key":"10.1124\/dmd.120.090886_bib59","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.bcp.2009.05.026","article-title":"Effect of P-glycoprotein-mediated efflux on cerebrospinal fluid concentrations in rhesus monkeys","volume":"78","author":"Tang","year":"2009","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/dmd.120.090886_bib60","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/nrneurol.2015.119","article-title":"Clearance systems in the brain-implications for Alzheimer disease","volume":"11","author":"Tarasoff-Conway","year":"2015","journal-title":"Nat Rev Neurol"},{"key":"10.1124\/dmd.120.090886_bib61","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1016\/S0022-3565(24)36945-9","article-title":"Distributed model analysis of 3\u2032-azido-3\u2032-deoxythymidine and 2\u2032,3\u2032-dideoxyinosine distribution in brain tissue and cerebrospinal fluid","volume":"282","author":"Takasawa","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.120.090886_bib62","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/S0076-6879(06)13002-5","article-title":"Preparation of amyloid beta-protein for structural and functional studies","volume":"413","author":"Teplow","year":"2006","journal-title":"Methods Enzymol"},{"key":"10.1124\/dmd.120.090886_bib63","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.jalz.2019.03.009","article-title":"Plasma amyloid \u03b2 40\/42 ratio predicts cerebral amyloidosis in cognitively normal individuals at risk for Alzheimer\u2019s disease","volume":"15","author":"Vergallo","year":"2019","journal-title":"Alzheimers Dement"},{"key":"10.1124\/dmd.120.090886_bib64","doi-asserted-by":"crossref","first-page":"5823","DOI":"10.1074\/jbc.274.9.5823","article-title":"Proteolytic processing of the Alzheimer\u2019s disease amyloid precursor protein within its cytoplasmic domain by caspase-like proteases","volume":"274","author":"Weidemann","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1124\/dmd.120.090886_bib65","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1208\/s12248-012-9366-1","article-title":"Physiologically based pharmacokinetic modeling to investigate regional brain distribution kinetics in rats","volume":"14","author":"Westerhout","year":"2012","journal-title":"AAPS J"},{"key":"10.1124\/dmd.120.090886_bib66","doi-asserted-by":"crossref","first-page":"34554","DOI":"10.1074\/jbc.M801487200","article-title":"The low density lipoprotein receptor-related protein 1 mediates uptake of amyloid beta peptides in an in vitro model of the blood-brain barrier cells","volume":"283","author":"Yamada","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1124\/dmd.120.090886_bib67","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.ejps.2017.11.011","article-title":"Prediction of human CNS pharmacokinetics using a physiologically-based pharmacokinetic modeling approach","volume":"112","author":"Yamamoto","year":"2018","journal-title":"Eur J Pharm Sci"},{"key":"10.1124\/dmd.120.090886_bib71","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1006\/exnr.1994.1076","article-title":"Distribution of intracerebral ventricularly administered neurotrophins in rat brain and its correlation with trk receptor expression","volume":"127","author":"Yan","year":"1994","journal-title":"Exp Neurol"},{"key":"10.1124\/dmd.120.090886_bib68","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0006-8993(01)03008-6","article-title":"Relationship between beta amyloid peptide generating molecules and neprilysin in Alzheimer disease and normal brain","volume":"919","author":"Yasojima","year":"2001","journal-title":"Brain Res"},{"key":"10.1124\/dmd.120.090886_bib69","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1124\/dmd.112.050344","article-title":"Drug transporters on arachnoid barrier cells contribute to the blood-cerebrospinal fluid barrier","volume":"41","author":"Yasuda","year":"2013","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.120.090886_bib70","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1038\/77397","article-title":"Clearance of amyloid beta-peptide from brain: transport or metabolism?","volume":"6","author":"Zlokovic","year":"2000","journal-title":"Nat Med"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624077389?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624077389?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/dmd.120.090886","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T09:19:37Z","timestamp":1739956777000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955624077389"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":66,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["S0090955624077389"],"URL":"https:\/\/doi.org\/10.1124\/dmd.120.090886","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Human Amyloid-\u03b240 Kinetics after Intravenous and Intracerebroventricular Injections and Calcitriol Treatment in Rats In Vivo","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/dmd.120.090886","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}